Pleuropneumonia

01/01/2013 - "A better understanding of how T1 vaccination confers immunity would facilitate the rational design of improved vaccines against contagious bovine pleuropneumonia (CBPP). "
06/01/2004 - "To evaluate the efficacy of two new-generation porcine pleuropneumonia vaccines when challenged with Australian isolates of Actinobacillus pleuropneumoniae of serovars 1 and 15. "
01/01/1972 - "The efficacy of T strain broth vaccine against contagious bovine pleuropneumonia: in-contact trials carried out two years after primary vaccination."
01/10/1970 - "The efficacy of T1 strain broth vaccine against contagious bovine pleuropneumonia: in-contact trials carried out six and twelve months after primary vaccination."
01/01/2015 - "Mathematical modelling of the transmission dynamics of contagious bovine pleuropneumonia reveals minimal target profiles for improved vaccines and diagnostic assays."

08/20/1999 - "Aerosol immunization is a safe way to induce complete protection against pleuropneumonia in pigs caused by the lung pathogenic bacterium Actinobacillus pleuropneumoniae. "
11/16/2020 - "Reproduction of contagious bovine pleuropneumonia via aerosol-based challenge with Mycoplasma mycoides subsp. "
03/01/2013 - "Actinobacillus pleuropneumoniae is the aetiological agent of porcine pleuropneumonia and is normally transmitted by aerosols and direct contact between animals. "
07/01/2000 - "In aerosol challenge experiments, pigs developed acute pleuropneumonia following exposure to high doses (10(6) cfu/mL) of the parental strain, CM5 Nalr, and to the cbiK::Tn10 mutant. "
11/01/1993 - "Following challenge with live bacteria two weeks after the last exposure to the aerosol, the immunised pigs were protected from the severe pleuropneumonia which developed in non-immunised pigs. "

03/01/2014 - "In this study, the Actinobacillus pleuropneumoniae antigens ApxIA, ApxIIA, ApxIIIA and OmpA were expressed in an attenuated strain of Salmonella (∆lon∆cpxR∆asd) for prevention of porcine pleuropneumonia. "
01/01/1965 - "II. FURTHER STUDIES ON THE PRECIPITATING ANTIGENS IN THE BODY FLUIDS FROM CASES OF CONTAGIOUS BOVINE PLEUROPNEUMONIA."
08/12/2022 - "Immune and Oxidative Response against Sonicated Antigen of Mycoplasma capricolum subspecies capripneumonia-A Causative Agent of Contagious Caprine Pleuropneumonia."
03/01/2014 - "Optimization of immune strategy for a construct of Salmonella-delivered ApxIA, ApxIIA, ApxIIIA and OmpA antigens of Actinobacillus pleuropneumoniae for prevention of porcine pleuropneumonia using a murine model."
06/01/1993 - "Two antigens of polysaccharidic nature were evaluated for their specificity in serodiagnosis of porcine pleuropneumonia (serotype 5). "

03/01/2016 - "Recombinant Mycoplasma mycoides proteins elicit protective immune responses against contagious bovine pleuropneumonia."
07/01/2010 - "A lateral flow protein microarray for rapid determination of contagious bovine pleuropneumonia status in bovine serum."
02/01/2008 - "mycoides SC were analysed to determine whether these proteins are expressed in vivo in animals affected by contagious bovine pleuropneumonia (CBPP) and in vitro. "
10/01/2005 - "The purified protein reacted strongly with the standard positive serum and didn't react with the negative sera of contagious bovine pleuropneumonia(CBPP)."
01/15/2004 - "Expression of Actinobacillus pleuropneumonia gene coding for Apx I protein in Escherichia coli."

03/01/1968 - "Preliminary studies on living culture and inactivated vaccines against contagious bovine pleuropneumonia."
10/24/1987 - "An inactivated vaccine for contagious caprine pleuropneumonia."
10/01/1986 - "Observations on experimental inactivated vaccines for contagious bovine pleuropneumonia."
02/01/1985 - "Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae."
10/01/1986 - "In two trials the efficacy of inactivated vaccines against contagious bovine pleuropneumonia was tested by exposing vaccinated cattle to droplet infection provided by close contact with experimentally infected 'donors'. "

01/01/2015 - "mycoides is responsible for contagious bovine pleuropneumonia and is known to produce capsular polysaccharide (CPS) and exopolysaccharide (EPS). "
05/01/2000 - "The capsular polysaccharides (CPS) play a major role in pathogenicity of Actinobacillus pleuroIpneumoniae, the causative agent of porcine pleuropneumonia. "
02/01/2002 - "Capsular polysaccharide conjugate vaccines against contagious bovine pleuropneumonia: Immune responses and protection in mice."
01/01/1997 - "A saline boiled extract (SBE), capsular polysaccharides (CPS) and long-chain lipopolysaccharides (LC-LPS) of Actinobacillus pleuropneumoniae serotype 7 have been evaluated in ELISA for the serodiagnosis of swine pleuropneumonia caused by this serotype. "
11/01/1994 - "A saline boiled extract (SBE), capsular polysaccharides (CPS) and long-chain lipopolysaccharides (LC-LPS) of Actinobacillus pleuropneumoniae serotype 1 have been evaluated in ELISA for the serodiagnosis of swine pleuropneumonia caused by this serotype. "

02/24/2014 - "An international collaborative study to determine the prevalence of contagious caprine pleuropneumonia by monoclonal antibody-based cELISA."
08/01/1994 - "The use of monoclonal antibodies in the diagnosis of contagious caprine pleuropneumonia (CCPP)."
06/18/1994 - "Serological specificity of a monoclonal antibody to Mycoplasma capricolum strain F38, the agent of contagious caprine pleuropneumonia."
06/01/1993 - "Seventeen monoclonal antibodies (MAbs) raised against Mycoplasma mycoides ssp. mycoides small colony type (Mmm SC), the causative agent of contagious bovine pleuropneumonia (CBPP), were partially characterised. "
06/01/1993 - "Improvements in the diagnosis of contagious bovine pleuropneumonia through the use of monoclonal antibodies."

02/01/1985 - "A bacterin containing serotypes 1 and 5 of Haemophilus pleuropneumoniae was developed for the prevention and the control of porcine pleuropneumonia. "
12/01/2019 - "A systematic review and network meta-analysis (MA) was conducted to address the question, 'What is the efficacy of bacterial vaccines to prevent respiratory disease in swine?' Four electronic databases and the grey literature were searched to identify clinical trials in healthy swine where at least one intervention arm was a commercially available vaccine for one or more bacterial pathogens associated with respiratory disease in swine, including Mycoplasma hyopneumoniae, Actinobacillus pleuropneumonia, Actinobacillus suis, Bordetella bronchiseptica, Pasteurella multocida, Stretococcus suis, Haemophils parasuis, and Mycoplasma hyorhinis. "

01/01/2018 - "Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs."
01/01/2018 - "A blinded, controlled, randomized and blocked dose confirmation study was conducted to test the efficacy and safety of a single dose of 8 mg/kg marbofloxacin (160 mg/ml, Forcyl® Swine, Vetoquinol SA, France) to treat acute porcine pleuropneumonia after experimental aerosol inoculation of pigs with A. "

10/17/2013 - "mycoides (Mmm), the causal agent of contagious bovine pleuropneumonia (CBPP) has been identified as a virulence factor responsible for the release of toxic by-products such as H2O2 that mediate host cell injury. "
01/06/2010 - "suis shares many virulence factors in common with Actinobacillus pleuropneumoniae and can cause a haemorrhagic pleuropneumonia similar to that caused by A. "
10/01/2009 - "Apx toxins have been identified as important virulence factors of Actinobacillus pleuropneumoniae, the etiologic agent of porcine pleuropneumonia. "
07/01/2009 - "Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, produces Apx toxins that are recognized as major virulence factors. "
12/01/2008 - "Actinobacillus pleuropneumoniae, the causative bacterial agent of porcine pleuropneumonia, produces Apx toxins which belong to RTX toxin family and are recognized as the major virulence factors. "

08/01/1997 - "Combination of medical and surgical therapy for pleuropneumonia in a horse."
10/01/1985 - "Comparison of common antibiotic therapies for haemophilus pleuropneumonia in pigs."
06/01/2022 - "BackgroundSystemic lupus erythematosus (SLE) is a rheumatological disorder with a heterogeneous clinical presentation and disease course. Case presentationWe report a case concerning a young woman with pleuropneumonia, non-responsive to conventional antibiotic therapy, who was, upon further inquiry and passage of time, diagnosed with SLE. Key pointsBy means of this case, we would like to emphasize the clinical implications and prognostic significance of lymphopenia in patients with SLE. "
01/01/1996 - "The experience with ofloxacin used for 10 years from 1986 to 1995 in the complex therapy of 208 patients with wound infection complicated in 51 patients (24.5 per cent) by respiratory tract infection such as purulent tracheobronchitis or pleuropneumonia was generalized. "
01/01/2020 - "It is presented the case of a 4-year-old patient who entered Intensive Therapy Unit with pleuropneumonia due to Streptococcus pneumoniae serotype 6C and concomitantly developed edemas, arterial hypertension, hematuria, proteinuria, decreased glomerular filtration rate and C3 complement level. "

05/01/2017 - "Thoracotomy should be considered as a treatment for pleuropneumonia."
10/01/2010 - "Standing lateral thoracotomy should be considered for the treatment of complicated pleuropneumonia in horses."
01/01/2021 - "Thoracotomy is an uncommon procedure in horses but remains essential in a variety of cases of pleuropneumonia, pericarditis, thoracic trauma or diaphragmatic herniation, and for experimental thoracic and cardiac procedures. "

09/01/2012 - "Combination fibrinolytic therapy in the treatment of chronic septic pleuropneumonia in a Thoroughbred gelding."
05/02/2009 - "Intrapleural fibrinolytic therapy in the management of septic pleuropneumonia in a horse."

06/01/1996 - "However, one patient had a postoperative left-sided pleuropneumonia that required prolonged hospital stay. "
07/01/2018 - "Children presented with a leukemoid reaction are at high risk of pneumonia, especially pleuropneumonia, and a long hospital stay. "

07/19/2023 - "Particularly, we describe a case of pleuropneumonia (4 year old boy) and a case of respiratory failure (2 year old boy), who necessitated Non-Invasive Ventilation support, a case of Streptococcal Toxic Shock Syndrome (6 year old girl), presenting with multi-organ failure, who needed Invasive Ventilation, and a case of meningitis (5 year old girl). "